Surgery and OncologySurgery and OncologyХирургия и онкология2949-5857Publishing House ABV Press7710.17650/2220-3478-2014-0-3-29-34ORIGINAL REPORTSОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯPREOPERATIVE CHEMOTHERAPY FOR COLORECTAL CANCER LIVER METASTASES: SHORT-TERM RESULTSНЕПОСРЕДСТВЕННАЯ ЭФФЕКТИВНОСТЬ ПРЕДОПЕРАЦИОННОЙ ХИМИОТЕРАПИИ ПРИ МЕТАСТАЗАХ КОЛОРЕКТАЛЬНОГО РАКА В ПЕЧЕНИChernoglazovaE. V.ЧерноглазоваЕ. В.Russian Federationev-onco@mail.ruVyshinskayaG. V.ВышинскаяГ. В.Russian Federationev-onco@mail.ruGutorovS. L.ГуторовС. Л.Russian Federationev-onco@mail.ruSagaydakI. V.СагайдакИ. В.Russian Federationev-onco@mail.ruPolyakovA. N.ПоляковА. Н.Russian Federationev-onco@mail.ruVishnevskayaYа. V.ВишневскаяЯ. В.Russian Federationev-onco@mail.ruPatyutkoYu. I.ПатюткоЮ. И.Russian Federationev-onco@mail.ruLichinitserM. R.ЛичиницерМ. Р.Russian Federationev-onco@mail.ruDepartment of Combined Methods of Treatment N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowОтделение химиотерапии и комбинированных методов лечения злокачественных опухолей ФГБУ РОНЦ им. Н.Н. Блохина РАМН, МоскваDepartment of Liver and Pancreatic Tumor Surgery N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowХирургическое отделение опухолей печени и поджелудочной железы ФГБУ РОНЦ им. Н.Н. Блохина РАМН, МоскваPathology Department FSBI N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoПаталогоанатомическое отделение ФГБУ РОНЦ им. Н.Н. Блохина РАМН, Москва260920143329342802201528022015Copyright ©; 2014, Chernoglazova E.V., Vyshinskaya G.V., Gutorov S.L., Sagaydak I.V., Polyakov A.N., Vishnevskaya Y.V., Patyutko Y.I., Lichinitser M.R.Copyright ©; 2014, Черноглазова Е.В., Вышинская Г.В., Гуторов С.Л., Сагайдак И.В., Поляков А.Н., Вишневская Я.В., Патютко Ю.И., Личиницер М.Р.2014Chernoglazova E.V., Vyshinskaya G.V., Gutorov S.L., Sagaydak I.V., Polyakov A.N., Vishnevskaya Y.V., Patyutko Y.I., Lichinitser M.R.Черноглазова Е.В., Вышинская Г.В., Гуторов С.Л., Сагайдак И.В., Поляков А.Н., Вишневская Я.В., Патютко Ю.И., Личиницер М.Р.https://creativecommons.org/licenses/by/4.0https://onco-surgery.info/jour/article/view/77colorectal cancer liver metastasespreoperative chemotherapypathologic responseметастазы колоректального рака в печенипредоперационная химиотерапиялечебный патоморфоз[1. Давыдов М.И. и Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2009 г. Вестник РОНЦ им. Н.Н. Блохина РАМН 2011;22(3), прил. 1.Давыдов М.И. и Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2009 г. Вестник РОНЦ им. Н.Н. Блохина РАМН 2011;22(3), прил. 1.][2. Jemal А., Bray F., Center М.М. et al. Global cancer statistics. CA Cancer J Clin 2011;61(2):69–90.Jemal А., Bray F., Center М.М. et al. Global cancer statistics. CA Cancer J Clin 2011;61(2):69–90.][3. Pawlik T.M., Schulick R.D., Choti M.A. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008;13(1):51–64.Pawlik T.M., Schulick R.D., Choti M.A. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008;13(1):51–64.][4. Schmoll H.J., Van Cutsem E., Stein A. et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol 2012 Oct;23(10): 2479–516.Schmoll H.J., Van Cutsem E., Stein A. et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol 2012 Oct;23(10): 2479–516.][5. Nordlinger B., Sorbye H., Glimelius B. et al. Perioperative chemotherapy with FOLFOX4 and surgery vs. surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup Trial 40983): a randomized controlled trial. Lancet 2008; 371:1007–16.Nordlinger B., Sorbye H., Glimelius B. et al. Perioperative chemotherapy with FOLFOX4 and surgery vs. surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup Trial 40983): a randomized controlled trial. Lancet 2008; 371:1007–16.][6. Ciliberto D., Prati U., Roveda L. et al. Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and metaanalysis of randomized controlled trials. Oncol Rep 2012 Jun;27(6):1849–56.Ciliberto D., Prati U., Roveda L. et al. Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and metaanalysis of randomized controlled trials. Oncol Rep 2012 Jun;27(6):1849–56.][7. Zhu D., Zhong Y., Wei Y. et al. Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. PLoS One 2014 Jan 21;9(1):e86543.Zhu D., Zhong Y., Wei Y. et al. Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. PLoS One 2014 Jan 21;9(1):e86543.][8. Benoist S., Brouquet A., Penna C. et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006 Aug 20;24(24):3939–45.Benoist S., Brouquet A., Penna C. et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006 Aug 20;24(24):3939–45.][9. Gaujoux S., Goйrй D., Dumont F. et al. Complete radiological response of colorectal liver metastases after chemotherapy: what can we expect? Dig Surg 2011;28(2):114–20.Gaujoux S., Goйrй D., Dumont F. et al. Complete radiological response of colorectal liver metastases after chemotherapy: what can we expect? Dig Surg 2011;28(2):114–20.][10. Therasse P., Arbuck S.G., Eisenhauer E.A. et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92(3): 205–16.Therasse P., Arbuck S.G., Eisenhauer E.A. et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92(3): 205–16.][11. Патолого-анатомическая диагностика опухолей человека. Руководство для врачей в 2 томах под ред. Н.А. Краевского, А.В. Смольянникова, Д.С. Саркисова. М.: Медицина, 1993. С. 134–135.Патолого-анатомическая диагностика опухолей человека. Руководство для врачей в 2 томах под ред. Н.А. Краевского, А.В. Смольянникова, Д.С. Саркисова. М.: Медицина, 1993. С. 134–135.][12. American Joint Committee on Cancer. Colon and rectum. In: AJCC Сancer Staging Manual. 6th ed. New York: Springer, 2002. P. 113–124.American Joint Committee on Cancer. Colon and rectum. In: AJCC Сancer Staging Manual. 6th ed. New York: Springer, 2002. P. 113–124.][13. Патютко Ю.Т., Сагайдак И.В., Котельников А.Г. и др. Резекция печени: современные технологии при опухолевом поражении. Анналы хирургической гепатологии 2010;15(2):10–7.Патютко Ю.Т., Сагайдак И.В., Котельников А.Г. и др. Резекция печени: современные технологии при опухолевом поражении. Анналы хирургической гепатологии 2010;15(2):10–7.][14. Karoui M., Penna C., Amin-Hashem M. et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1–7.Karoui M., Penna C., Amin-Hashem M. et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1–7.][15. Aloia Т.A., Vauthey J.N., Loyer E.M. et al. Resection of colorectal liver metastases. Arch Surg– 2006;141:460–7.Aloia Т.A., Vauthey J.N., Loyer E.M. et al. Resection of colorectal liver metastases. Arch Surg– 2006;141:460–7.]